Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Papers
, 2000, 'Mechanisms involved in the development of hypochlorhydria and pangastritis in Helicobacter pylori infection', in Hunt RH; Tytgat GNJ (ed.), HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, SPRINGER, BERMUDA, pp. 373 - 384, presented at 4th Symposium on Helicobacter Pylori - Basic Mechanisms to Clinical Cure, BERMUDA, 26 March 2000 - 29 March 2000, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167245700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1999, 'Effect of antral atrophy on gastric function in H-pylori infection:: Relevance to progression to pangastritis.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A249 - A249
, 1999, 'H pylori genotypes and clinical and histopathological findings in first degree relatives of patients with non-cardia gastric adenocarcinoma', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A154 - A154
, 1999, 'Symptomatic benefit 1-3 years post H-pylori eradication in ulcer patients:: Impact of reflux disease.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A249 - A249
, 1998, 'Ablation of fucosyl transferase homologs has varying effects on H-pylori Lewis antigen expression.', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A972 - A972, http://dx.doi.org/10.1016/S0016-5085(98)83958-9
, 1998, 'H-pylori induced hypochlorhydria and gastric atrophy associated with increased gastric cancer risk', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. 1A - 1A
, 1997, 'Degree of suppression of gastric acid secretion by omeprazole is related to H-pylori status.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A126 - A126
, 1997, 'H-pylori induced hypochlorhydria is associated with increased risk of gastric cancer.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A558 - A558
, 1997, 'H-pylori induced hypochlorhydria is associated with increased risk of gastric cancer.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. WA32 - WA32
, 1997, 'H-pylori infection and gastric acid hyposecretion', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. A30 - A30
, 1997, 'H-pylori-induced hypergastrinaemia is related to bacterial CagA status.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A215 - A215
, 1997, 'H-pylori-induced hypergastrinaemia is related to bacterial CagA status.', in GUT, BMJ PUBLISHING GROUP, pp. TH183 - TH183
, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. A45 - A45
, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. A1 - A1
, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A575 - A575
, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons.', in GUT, BMJ PUBLISHING GROUP, pp. TH184 - TH184
, 1997, 'Marked rebound acid hypersecretion following omeprazole therapy in H-pylori negative subjects.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A126 - A126
, 1997, 'Plasma glycine-extended gastrin concentrations and human colorectal cancer.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A638 - A638
, 1997, 'Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A293 - A293
, 1997, 'Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. W11 - W11
, 1997, 'Regulation of corpus mucosal function in Hp infected DU patients versus healthy volunteers.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A126 - A126
, 1997, 'Regulation of corpus mucosal function in HP infected DU patients versus healthy volunteers.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. W12 - W12
, 1997, 'Variable symptomatic response to H-pylori eradication in ulcer patients.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A215 - A215
, 1996, 'Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer', in Scandinavian Journal of Gastroenterology Supplement, pp. 32 - 37
, 1996, 'Divergent effects of H-pylori on acid secretion.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A102 - A102
, 1996, 'Evidence supporting a H-pylori test and treat strategy for simple dyspepsia.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A28 - A28
, 1996, 'Parietal cell sensitivity to gastrin distinguishes H-pylori infected DU patients from infected healthy volunteers', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A116 - A116
, 1995, 'GASTRIN AND ITS PRECURSORS IN HUMAN COLORECTAL-CANCER', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A524 - A524
, 1994, 'A SUBSTANTIAL PROPORTION OF NUD PATIENTS HAVE THE SAME ABNORMALITY OF ACID-SECRETION AS DU PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74
, 1994, 'EFFECT OF ALLOPURINOL ON GASTRODUODENAL MORPHOLOGY AND FUNCTION IN HELICOBACTER-PYLORI POSITIVE SUBJECTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A45 - A45
, 1994, 'FASTING AND MEAL-STIMULATED GASTRIN-LEVELS PREOPERATIVELY AND POSTOPERATIVELY IN COLORECTAL TUMOR PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A428 - A428
, 1994, 'HELICOBACTER-PYLORI IMPAIRS THE INHIBITORY CONTROL OF ACID-SECRETION IN DUODENAL-ULCER PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74
, 1994, 'MARKED REBOUND ACID HYPERSECRETION IN HEALTHY-VOLUNTEERS FOLLOWING RANITIDINE', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74
, 1994, 'SUCRALFATE SUPPRESSES HELICOBACTER-PYLORI INFECTION AND REDUCES GASTRIC-ACID SECRETION BY 50-PERCENT IN DU PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A45 - A45
, 1993, 'ERADICATING HELICOBACTER-PYLORI LOWERS GASTRIN-MEDIATED ACID-SECRETION BY 70-PERCENT IN DU PATIENTS AND BY 50-PERCENT IN HEALTHY-VOLUNTEERS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A75 - A75
, 1993, 'OMEPRAZOLE INHIBITS AZOXYMETHANE-INDUCED COLORECTAL CARCINOGENESIS IN RATS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A441 - A441
, 1992, 'ERADICATION OF HELICOBACTER-PYLORI INFECTION DURING LONG-TERM SULFASALAZINE THERAPY', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. S28 - S28
, 1992, 'ERADICATION OF HELICOBACTER-PYLORI LOWERS GASTRIN-MEDIATED ACID-SECRETION BY 70-PERCENT IN DU PATIENTS', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. S28 - S28
, 1987, 'SEPARATE SIGNALS ARE REQUIRED FOR THE STIMULATION OF HEPATIC SYNTHESIS OF THE 3RD AND 4TH COMPONENTS OF COMPLEMENT DURING THE ACUTE-PHASE RESPONSE', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. A68 - A68
, 1986, 'EFFECTS OF RIFAMPICIN ON HEME-BIOSYNTHESIS AND HEPATIC MONOOXYGENASE ACTIVITY IN HEALTHY-SUBJECTS', in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, BLACKWELL SCIENCE LTD, pp. P602 - P602
, 1985, 'NEW OBSERVATIONS IN GILBERTS SYNDROME', in SCOTTISH MEDICAL JOURNAL, HERMISTON PUBLICATIONS LTD, pp. 56 - 57
Conference Posters
, 2022, 'Characterization of gut microbiota and exploration of potential predictive model for hepatocellular carcinoma microvascular invasion', ENGLAND, London, Vol. 77, pp. S920 - S921, presented at International Liver Congress, ENGLAND, London, 22 June 2022 - 26 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000826275104366&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Presentations
, 2022, 'The MothersBabies Study: analysing the preconception microbiome to determine risk of adverse maternal-child health outcomes', presented at Brighter Beginnings First 2000 Days Summit, NSW Ministry of Health, 31 October 2022 - 01 November 2022, https://willorganise.eventsair.com/bb-first-2000-days-summit/day-2
Conference Abstracts
, 2026, 'COMPARISON OF THE EFFICACY AND GUT MICROBIOTA IMPACT OF VONOPRAZAN-BASED VERSUS LANSOPRAZOLE-BASED REGIMENS FOR FIRST-LINE HELICOBACTER PYLORI TREATMENT: A MULTICENTER OPEN-LABEL RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, Vol. 170, pp. S2521 - S2521, presented at Digestive Disease Week (DDW), IL, Chicago, 02 May 2026 - 05 May 2026
, 2026, 'IDENTIFICATION OF THE OPTIMAL SCREENING STRATEGY FOR HELICOBACTER PYLORI INFECTION FOR GASTRIC CANCER PREVENTION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, Vol. 170, presented at Digestive Disease Week (DDW), IL, Chicago, 02 May 2026 - 05 May 2026
, 2026, 'METABOLIC SYNDROME AND BODY COMPOSITION DISPLAY SEX-SPECIFIC EFFECTS ON AIRWAY INFLAMMATION AND CLINICAL ASTHMA OUTCOMES', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 56, pp. 6 - 7
, 2025, 'Case-control study on oral microbiome in females with RRMS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Brisbane, Vol. 32, presented at MS Australia's 10th Progress in MS Research Conference, AUSTRALIA, Brisbane, 03 December 2025 - 05 December 2025
, 2025, '235eP Influence of gut and oral microbiomes on chemotherapy survival status in gastrointestinal cancer patients in Australia', in Annals of Oncology, Elsevier, Vol. 36, pp. s298 - s299, http://dx.doi.org/10.1016/j.annonc.2025.08.665
, 2025, 'The Role of the Lower Airway Microbiome in Predicting Treatment Response to Immunotherapy in Patients With Non-Small Cell Lung Cancer', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, Vol. 20
, 2024, 'Abstract A029: Re-purposing non-oncology agent itraconazole to target the dynamic cellular ecosystem of pancreatic cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. a029 - a029, http://dx.doi.org/10.1158/1538-7445.panca2023-a029